Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Regenerating Islet-Derived 3 alpha (REG3A) (N-Term) Peptid

REG3A Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN982832
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 15 bis 22 Werktagen

Kurzübersicht für Regenerating Islet-Derived 3 alpha (REG3A) (N-Term) Peptid (ABIN982832)

Target

REG3A (Regenerating Islet-Derived 3 alpha (REG3A))

Spezies

Human

Quelle

  • 1
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequenz

    ECIKEANLFA LGPLVGDNFV RFLKGGALGV TRCLATRQKK KHLFVERGGG

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-REG3A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    REG3A (Regenerating Islet-Derived 3 alpha (REG3A))

    Hintergrund

    OSGIN2 may be involved in meiosis or the maturation of germ cells.

    Alias Symbols: HIP, PAP, PAP-H, PAP1, PBCGF, REG-III, REG3

    Protein Size: 505

    Molekulargewicht

    56 kDa

    Gen-ID

    5068

    NCBI Accession

    NM_002580, NP_002571

    UniProt

    Q06141
Sie sind hier:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!